Medicine and Dentistry
Adjuvant Chemoradiotherapy
17%
Androgen Receptor
17%
Anticonvulsant Therapy
17%
Ascites
26%
Bacterial Vaginosis
17%
Burkitt's Lymphoma
17%
CAG Repeat
17%
Carbon Dioxide
17%
Chemoradiotherapy
17%
Conservative Treatment
17%
Disease
60%
Disease Course
21%
Edema
17%
Elderly Patient
49%
Endometrial Cancer
56%
Endometrioid Carcinoma
17%
Endometrium Carcinoma
35%
Fine-Needle Aspiration
17%
Fluorouracil
17%
Folinic Acid
17%
Genital Wart
17%
Granular Cell Tumor
17%
Hysterectomy
38%
Krukenberg Tumor
100%
Laparoscopy
17%
Laparotomy
48%
Lymph Node
22%
Lymphadenopathy
17%
Malignant Ascites
17%
Neoadjuvant Chemotherapy
53%
Neoplasm
54%
Neutrophil
17%
Oncology
17%
Ovarian Cancer
58%
Overall Survival
32%
Pelvis
23%
Peritoneal Fibrosis
17%
Postoperative Period
17%
Prognostic Factor
17%
Progression Free Survival
25%
Receptor Gene
17%
Robot-Assisted Surgery
17%
Squamous Cell Carcinoma
17%
Surgery
23%
Symptom
22%
Thecoma
17%
Uterine Cervix Carcinoma
19%
Vaginal Ultrasonography
23%
Vulva
35%
Wound
22%
Keyphrases
Advanced Ovarian Carcinoma
35%
Advanced Squamous Cell Carcinoma
17%
Advanced Stage
41%
Ascites
21%
Between-group
19%
Blue Dye
23%
BRCA mutation Carriers
35%
Cervical Carcinoma
20%
Chemoradiation
17%
Chemotherapy
26%
Clinical Course
21%
Complete Responders
17%
Condyloma Acuminatum
17%
Cystic Lesion
17%
Disease-free Interval
28%
Elderly Patients
53%
Endometrial Cancer
56%
Endometrial Carcinoma
17%
Expression Pattern
17%
Granular Cell Tumor
21%
Gynecologic Oncology
17%
Heavily Pretreated
17%
Hysterectomy
18%
Inclusion Criteria
18%
Interval Cytoreduction
19%
Israeli Women
17%
Laparotomy
30%
Locally Advanced
17%
Neoadjuvant Chemotherapy
53%
Newly Diagnosed
17%
Non-specific Binding
17%
Oncology Patients
17%
Ovarian Cancer
49%
Ovarian Carcinoma
55%
Overall Survival
27%
Progression-free Survival
21%
Residual Disease
19%
Robotic Surgery
20%
Salpingo-oophorectomy
21%
Sclerosing Mesenteritis
17%
Sentinel Lymph Node
25%
Sentinel Lymph Node Mapping
35%
Simple Hysterectomy
35%
Stage IB2
17%
Stage IIIC
28%
Surgical Intervention
23%
Tumor
38%
Vulvar Squamous Cell Carcinoma
17%
Yogurt
17%
Young Patients
19%